Business Context and Reporting Period
This Form 8-K filing by DarioHealth Corp. (DRIO) reports a corporate governance event dated July 10, 2025. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive appointments and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Steven M. Nelson as President and Chief Commercial Officer, effective July 10, 2025. Mr. Nelson previously served as Chief Commercial Officer since June 5, 2024. His compensation remains unchanged from the terms previously disclosed in his May 29, 2024 offer letter.
Management Commentary and Risks
Management highlights Mr. Nelson's extensive background in healthcare leadership, including prior roles as President and CEO of Contigo Health, and various executive positions at Anthem (Elevance Health), Highmark Inc., and GNC Holdings. The filing states there are no undisclosed arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K related to this appointment.
Investor Verification Checklist
- Verify the effective date of Steven M. Nelson's promotion to President (July 10, 2025).
- Confirm that no changes to Mr. Nelson's compensation package were made relative to the May 2024 offer letter.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.